Navigating Physician Side Gigs: Chart Review Risks and Rewards

By Elena Pak, Credentialing Department, WCH

Physicians are diversifying their income in record numbers. Chart review is the entry point for many. The legal landscape around it has never been more consequential.

There is nothing new about physicians earning money outside their primary clinical role. What is new is the scale, the normalization, and the enforcement environment those physicians are now stepping into.

A Medscape survey of more than 2,500 U.S. physicians found that nearly 4 in 10 doctors currently have a side gig. Among the most accessible and frequently cited options is chart review — evaluating medical files for insurers, workers’ compensation boards, or law firms. According to MGMA and physician workforce surveys, chart review ranks consistently among the top five physician side income sources alongside medical consulting, expert witness work, moonlighting, and speaking engagements. The appeal is straightforward: physicians can work from home, apply knowledge they already possess, and generate compensation ranging from $85 to $200 per hour for file review assignments without taking on additional clinical risk.

But chart review and other supplemental income arrangements exist within a legal environment that, in 2026, is operating at a scale and level of coordination not seen a decade ago. Physicians entering this space — or already operating within it — need to understand exactly what they are walking into.

The Compensation Pressure Is Real

Before analyzing risk, it is worth acknowledging what is driving the trend. Physician compensation growth has been among the slimmest in over a decade, while the share of physicians who report feeling fairly paid has hit a 10-year low according to Medscape compensation data. Against that backdrop, the appeal of supplemental income is not vanity. It reflects structural pressure that shows no sign of easing.

The traditional model — a single employer, a predictable salary, and perhaps an RVU bonus — is fracturing under economic strain. Across specialties, physicians are increasingly layering supplemental income streams onto their primary compensation, from workers’ compensation chart reviews to medical-legal consulting. Side gigs appear to have lasting power: among physicians who maintain one, the average tenure is a decade, making these not temporary experiments but permanent features of financial planning.

The single largest source of supplemental income for physicians remains extra clinical work — moonlighting, per-diem shifts, locums, telemedicine. But medical-legal work, including chart review and expert witness roles, is growing steadily in prevalence. The question facing physicians who pursue these opportunities is not whether they are worth pursuing. It is whether the specific arrangement being offered has been properly evaluated — not just for market rate and workload, but for legal structure.

The Enforcement Context Nobody Is Talking About

False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025 — the highest annual total in the history of the statute, and more than double the 10-year average. Over $5.7 billion of those recoveries related to healthcare matters, confirming that the healthcare fraud landscape remains DOJ’s primary enforcement focus.

The record-breaking recoveries were driven in part by a record 1,297 new qui tam lawsuits filed by whistleblowers — the most in any single year — with qui tam actions accounting for more than 77 percent of all settlements and judgments.

The statute underpinning most of these cases — the Anti-Kickback Statute (AKS) — prohibits offering, paying, soliciting, or receiving remuneration to induce or reward referrals of federal healthcare program business. Remuneration is broadly construed and includes anything of value.

Physicians are particularly exposed under the AKS because they can serve as referral sources for fellow providers, diagnostic companies, and vendors of healthcare goods and services. Even if a physician provided services that were medically necessary, they can still be found guilty of violating the AKS. Arguing that a provider would have rendered certain services or ordered certain equipment even without a kickback is not a viable defense.

Critically, intent analysis under the AKS is governed by what courts call the “one purpose test.” This doctrine was notably applied in United States v. Greber, where the court found that if one purpose of the payment was to induce future referrals, the AKS was violated, even if there were other legitimate reasons for the payment. This means an arrangement does not need to be built primarily around inducing referrals to be criminal — it only needs to have that as one purpose among several.

Where Chart Review Gets Complicated

Standard chart review — reviewing records for workers’ compensation boards, insurance carriers, or plaintiff attorneys — is generally low-risk when structured correctly. The physician is paid for time and expertise; there is no referral relationship; the compensation does not vary with outcomes.

The risk profile changes sharply when any of the following features appear:

Payment that varies with volume or direction of findings. If a reviewing company pays more per case when the reviewing physician finds in a particular direction — routinely denying claims, or consistently certifying medical necessity — that structure warrants immediate legal scrutiny. Violations of the AKS can result in criminal penalties, civil monetary penalties, and exclusion from federal healthcare programs. The Civil Monetary Penalties Law provides for substantial per-violation fines and treble damages, and those figures are periodically adjusted upward by regulatory inflation adjustments.

Arrangements where the reviewing physician also refers patients to the entity paying them. Unlike the Stark Law, the AKS requires proof of intent, but violations carry severe consequences including criminal penalties, civil monetary penalties, and exclusion from federal healthcare programs. The one-purpose test means that even a partially corrupt intent is sufficient for liability.

Telemedicine chart review and remote order signing. This is arguably the highest-risk category in 2026. Federal prosecutors have repeatedly targeted arrangements in which physicians sign off on orders — for diagnostics, durable medical equipment, or other services — without meaningful patient contact, in exchange for flat fees per approval. The transcranial doppler brain scan prosecutions recently concluded in Boston included exactly this pattern across multiple related defendants. The physician signing the order, not just the company paying for it, bears individual criminal exposure.

“Turnkey” mobile diagnostic arrangements. When a third-party vendor offers a physician both a chart review contract and a revenue-sharing arrangement tied to diagnostics ordered through the physician’s practice, those two financial streams cannot be evaluated independently. Federal prosecutors look at the totality of the financial relationship. Compensation arrangements must be carefully designed to comply with the Stark Law and AKS; physicians can be paid salaries, productivity bonuses, or profit shares, but these must not be based on the volume or value of referrals for designated health services.

What Physicians Need to Do Before Signing

Get legal review of every supplemental income contract before signing. This is not standard boilerplate advice. In the Massachusetts TCD prosecutions, multiple defendants had signed contracts drafted to appear compliant. The economic reality underneath those contracts — per-test payments disguised as administrative service fees — is what drove the prosecution. A healthcare attorney reviewing the contract is not sufficient; that attorney needs to evaluate the full economic relationship, including how compensation actually tracks referral or order volume in practice.

Ask the question directly: does my pay vary with what I find or what I refer? If the answer is yes in any form, the structure requires safe harbor analysis. An arrangement must squarely satisfy each condition set forth in the applicable safe harbor to receive protection. There is no safe harbor protection for partial compliance, and the risk of any arrangement that implicates the AKS but does not fully satisfy a safe harbor is assessed on the totality of its facts and circumstances, including the intent of the parties.

“Fair market value” language in a contract is not a safe harbor by itself. FMV language was prominently present in the sham agreements at the center of every TCD prosecution. True FMV assessments require independent, contemporaneous documentation — not post-hoc justifications prepared after a government inquiry has begun. The Stark Law is a strict liability statute, meaning violations occur regardless of intent, and noncompliance results in denial of payment, refund obligations, and substantial civil monetary penalties.

Do not rely on the vendor’s legal opinions. Several physicians in the TCD cases were presented with documentation from the diagnostics company suggesting the arrangement was compliant. That documentation did not protect them. When a vendor provides turnkey services and handles most of the operational risk while you bill and refer, regulators scrutinize whether the provider is a genuine participant in the service or a conduit for billing.

Understand whistleblower exposure. Qui tam cases may be pursued by the government or the whistleblower, and this past year significant recoveries were obtained by both. When a qui tam action is successful, the whistleblower typically receives a portion of the recovery ranging between 15% and 30%. Any arrangement involving multiple parties — a billing employee, a co-reviewer, a scheduling coordinator — has multiple potential relators. Compliance programs should be designed with the assumption that any participant could go to federal authorities.

The Bigger Picture

The physician side gig economy is not going away. The compensation pressures driving it are structural. For many physicians, supplemental income has become a permanent feature of their financial architecture. What must change is the due diligence physicians bring to evaluating these arrangements.

FCA risk is no longer episodic or limited to billing errors. DOJ has become increasingly comfortable advancing broader FCA theories tied to compliance representations, operational controls, and corporate decision-making. The enforcement timeline is also instructive: the Massachusetts TCD scheme ran from 2013 to 2020, with sentencings completing only in early 2026. Arrangements entered into today may not face legal consequences for years — but they will face consequences.

The physicians who will navigate this landscape successfully are those who treat supplemental income arrangements with the same rigor they apply to any significant professional decision: with qualified legal counsel, transparent documentation, and a clear-eyed assessment of what the economic reality of the arrangement actually is — not just what the contract says it is.

If you enjoyed this piece, subscribe to our monthly newsletter to receive even more in-depth insights.

Sources